R
Rakesh K. Jain
Researcher at Harvard University
Publications - 1528
Citations - 198912
Rakesh K. Jain is an academic researcher from Harvard University. The author has contributed to research in topics: Angiogenesis & Cancer. The author has an hindex of 200, co-authored 1467 publications receiving 177727 citations. Previous affiliations of Rakesh K. Jain include Government Medical College, Thiruvananthapuram & University of Oslo.
Papers
More filters
Journal ArticleDOI
Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab.
TL;DR: Analysis of data from a retrospective IRB-approved electronic chart review of newly diagnosed WHO grade 2–4 glioma patients from the Kaiser Permanente Tumor Registry of Northern California warrants prospective evaluation of adding ASI to low-dose BEV treatment in GBM patients to improve the outcome of standard therapies.
Journal ArticleDOI
Exercise Training Improves Tumor Control by Increasing CD8+ T-cell Infiltration via CXCR3 Signaling and Sensitizes Breast Cancer to Immune Checkpoint Blockade.
Igor L. Gomes-Santos,Zohreh Amoozgar,Ashwin S. Kumar,William Ho,Kangsan Roh,Nilesh Talele,Hannah Curtis,Kosuke Kawaguchi,Rakesh K. Jain,Dai Fukumura +9 more
TL;DR: In this article, the authors examined the causal role of CD8+ T cells in the benefit acquired from ExTr in tumor control, as well as the ability of ExTr to improve immunotherapy responses.
Journal ArticleDOI
Therapeutic implications of tumor physiology.
TL;DR: The physiologic barriers to the delivery of these agents to tumors and some strategies to overcome or exploit tumor physiology for therapeutic benefit are discussed.
Journal ArticleDOI
Total Synthesis of 3'-O-Sialyl, 6'-O-Sulfo Lewisx, NeuAc.alpha.2.fwdarw.3(6-O-SO3Na)Ga1.beta.1.fwdarw.4(Fuc.alpha.1.fwdarw.3)GlcNAc.beta.-OMe: A Major Capping Group of GLYCAM-I
Journal ArticleDOI
Chemotaxis of Burkholderia sp. Strain SJ98 towards chloronitroaromatic compounds that it can metabolise
Janmejay Pandey,Narinder K. Sharma,Fazlurrahman Khan,Anuradha Ghosh,John G. Oakeshott,Rakesh K. Jain,Gunjan Pandey +6 more
TL;DR: Its chemotactic responses towards six chloro-nitroaromatic compounds are related to its previously demonstrated chemotaxis towards NACs that it can metabolise, but it is independently inducible from its chemOTaxis towards succinate or aspartate.